HEPARIN INHIBITS P388D1 CELLS ADHERENCE AND METASTASIS TO PERIPHERAL LYMPH NODES IN VITRO AND IN VIVO

Lymphology

Volumn 42, Issue 1, 2009, Pages 10-18

  Wei, W ^a,b   Zuo, Y ^a,b   Hu, Y ^a   Wang, L ^b   Jia, L ^a   Zhang, J ^a,b  

^a Departments of Biochemistry and Molecular Biology   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Heparin; Metastasis; P388D1 macrophage like lymphoma cell line; Peripheral lymph nodes

Indexed keywords

HEPARIN; L SELECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL HOMING; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA P 388 CELL; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD147; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HEPARIN; L-SELECTIN; LEUKEMIA P388; LYMPHATIC METASTASIS; MICE; MICE, INBRED DBA;

EID: 66249140553     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Chen, M, JG Geng: P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch. Immunol. Ther. Exp. (Warsz) 54 (2006), 75-84.
2. Rodgers, SD, RT Camphausen, DA Hammer: Sialyl lewisX-mediated, PSGL-1-independent rolling adhesion on P-selectin. J. Biophys. 79 (2000), 694-706.
3. Burdick, MM, JT Chu, S Godar, et al: HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells. J. Biol. Chem. 281 (2006), 13899-13905.
4. Coskun, U, B Sancak, I Sen, et al: Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages. Int. Immunopharmacol. 6 (2006). 672-677.
5. Kobzdej, MMA, A Leppanen, V Ramachandran, et al: Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells. Blood 100 (2002), 4485-4494.
6. Witz. IP: Tumor-microenvironment interactions: The selectin-selectin ligand axis in tumor-endothelium cross talk. Cancer Treat. Res. 130 (2006), 125-140.
7. Bruehl, RE, CR Bertozzi, SD Rosen: Minimal sulfated carbohydrates for recognition by L-selectin and the MECA-79 antibody. J. Biol. Chem. 275 (2000), 32642-32648.
8. Borsig, L: Selectins facilitate carcinoma metastasis and heparin can prevent them. Physiology 19 (2004), 16-21.
9. Borsig, L, R Wong, RO Hynes, et al: (2002) Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc. Natl. Acad. Sci. USA 99 (2002), 2193-2198.
10. Yaris, N, M Buyukpamukcu, E Kansu: Expression of adhesion molecules LFA-1, ICAM-1, CD44, and L-selectin in childhood non-Hodgkin lymphomas. Med. Pediatr. Oncol. 36 (2001), 359-364.
11. Belanger, SD, Y St-Pierre: Role of selectins in the triggering, growth, and dissemination of T-lymphoma cells: Implication of L-selectin in the growth of thymic lymphoma. Blood 105 (2005), 4800-4806.
12. Zuo, Y, W Wei, C Liu, et al: Silencing L-selectin expression by siRNA attenuated metastasis of murine lymphoid neoplasm cell P388D1 to peripheral lymph nodes. Leukemia 21 (2007), 180-183.
13. Chong, BH. Heparin-induced thrombocytopenia. J. Thromb. Haemost. 1 (2003), 1471-1478.
14. Rosen, SD: Ligands for L-selectin: Homing, inflammation, and beyond. Ann. Rev. Immunol. 22 (2004), 129-156.
15. Warkentin, TE: Heparin-induced skin lesions. Br. J. Haematol. 92 (1996), 494-497.
16. Wei, M, G Tai, Y Gao, et al: Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions. J. Biol. Chem. 279 (2004), 29202-29210.
17. Ludwig, RJ, B Boehme, M Podda, et al: Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res. 64 (2004), 2743-2750.
18. Borsig, L, R Wong, J Feramisco, et al: Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc. Natl. Acad. Sci. USA 98 (2001), 3352-3357.
19. Matsui, NM, A Varki, SH Embury: Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin. Blood 100 (2002), 3790-3796.
20. Stevenson, JL, SH Choi, A Varki: Differential metastasis inhibition by clinically relevant levels of heparins-correlation with selectin inhibition, not antithrombotic activity. Clin. Cancer Res. 11 (2005), 7003-7011
21. Lee AYY, FR Rickles, JA Julian, et al: Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J. Clin. Oncol. 23 (2005), 2123-2129.
22. Alifano, M, G Benedetti, R Trisolini: Can low-molecular-weight heparin improve the outcome of patients with operable non-small cell lung cancer? An Urgent Call for Research. Chest 126 (2004), 601-607.
23. Vander Top, EA, GA Perry, MJ Gentry-Nielsen: A novel flow cytometric assay for measurement of in vivo pulmonary neutrophil phagocytosis. BMC Microbiol. 6 (2006), 61.
24. Heikki, I, J Eva-Liz, G Reidar, et al: Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J. Ext. Med. 194 (2001), 1033-1042.
25. Scimone, ML, I Aifantis, I Apostolou, et al: (2006) A multistep adhesion cascade for lymphoid progenitor cell homing to the thymus. Proc. Natl. Acad. Sci USA 103 (2006), 7006-7011.
26. Collen, A, SM Smorenburg, E Peters, et al: Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res. 60 (2000), 6196-6200.
27. Mitsi, M, Z Hong, CE Costello, et al: Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry 45 (2006), 10319-10328.
28. Nishi, E, Y Hiraoka, K Yoshida, et al: Nardilysin enhances ectodomain shedding of heparin-binding EGF-like growth factor through activation of TNF-alpha converting enzyme. J. Biol. Chem. 281 (2006) 31164-31172.
29. Pukac, LA, ME Ottlinger, MJ Karnovsky: Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J. Biol. Chem. 6 (1992), 3707-3711.
30. Wright, TC Jr, LA Pukac, JJ Castellot Jr, et al: Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc. Natl. Acad. Sci. USA 86 (1989), 3199-3203.
31. Ma, YQ, JG Geng: Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 Cells to P-Selectin under flow. J. Immunol. 165 (2000), 558-565.
32. Stevenson, JL, A Varki, L Borsig: Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects. Thromb. Res. 120 Suppl 2 (2007), S107-111.